Skip to main content
Top
Published in: American Journal of Clinical Dermatology 4/2003

01-04-2003 | Therapy In Practice

Hypertrophic Scars and Keloids

Etiology and Management

Authors: Dr Tina S. Alster, Elizabeth L. Tanzi

Published in: American Journal of Clinical Dermatology | Issue 4/2003

Login to get access

Abstract

Keloid and hypertrophic scars have affected patients and frustrated physicians for centuries. Keloid and hypertrophic scars result from excessive collagen deposition, the cause of which remains elusive. Clinically, these scars can be disfiguring functionally, aesthetically, or both. A thorough understanding of the pathophysiology and clinical nature of the scar can help define the most appropriate treatment strategy.
Although many articles have been published on the management of hypertrophic and keloid scars, there is no universally accepted treatment protocol. Prevention of keloid and hypertrophic scars remains the best strategy; therefore, those patients with a predisposition to develop excessive scar formation should avoid nonessential surgery. Once a scar is present, there are many treatments from which to choose. Hypertrophic scars and keloids have been shown to respond to radiation, pressure therapy, cryotherapy, intralesional injections of corticosteroid, interferon and fluorouracil, topical silicone or other dressings, and pulsed-dye laser treatment. Simple surgical excision is usually followed by recurrence unless adjunct therapies are employed. Biologic agents that are directed towards the aberrant collagen proliferation that characterizes keloid and hypertrophic scars might be an important addition to the current armamentarium of modalities in the near future.
Literature
1.
go back to reference Breasted HG. The Edwin Smith surgical papyrus: hieroglyphic translation and commentary. Chicago: University of Chicago Press, 1930 Breasted HG. The Edwin Smith surgical papyrus: hieroglyphic translation and commentary. Chicago: University of Chicago Press, 1930
2.
go back to reference Alibert JLM. Quelques recherches sur la cheloide. Mem Soc Medicale d’Emulation 1917; 8: 744–752 Alibert JLM. Quelques recherches sur la cheloide. Mem Soc Medicale d’Emulation 1917; 8: 744–752
3.
go back to reference Urioste SS, Arndt KA, Dover JS. Keloidal scars and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999; 18: 159–171PubMedCrossRef Urioste SS, Arndt KA, Dover JS. Keloidal scars and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999; 18: 159–171PubMedCrossRef
4.
go back to reference Muir IFK. On the nature of keloidal scars and hypertrophic scars. Br J Plast Surg 1990; 43: 61–69PubMedCrossRef Muir IFK. On the nature of keloidal scars and hypertrophic scars. Br J Plast Surg 1990; 43: 61–69PubMedCrossRef
5.
go back to reference Niessen FE, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloidal scars: a review. Plast Reconstr Surg 1999; 105: 1435–1458 Niessen FE, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloidal scars: a review. Plast Reconstr Surg 1999; 105: 1435–1458
6.
go back to reference Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990; 43: 276–280 Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990; 43: 276–280
7.
go back to reference Cosman B, Crikelair GF, Ju MC, et al. The surgical treatment of keloidal scars. Plast Reconstr Surg 1961; 27: 335–358CrossRef Cosman B, Crikelair GF, Ju MC, et al. The surgical treatment of keloidal scars. Plast Reconstr Surg 1961; 27: 335–358CrossRef
8.
go back to reference Larrabee Jr WF, East CA, Jaffe HS, et al. Intralesional interferon gamma treatment for keloidal scars and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159–1162PubMedCrossRef Larrabee Jr WF, East CA, Jaffe HS, et al. Intralesional interferon gamma treatment for keloidal scars and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159–1162PubMedCrossRef
9.
go back to reference Pollack SV, Goslen JB. The surgical treatment of keloidal scars. J Dermatol Surg Oncol 1982; 8: 1045–1049PubMed Pollack SV, Goslen JB. The surgical treatment of keloidal scars. J Dermatol Surg Oncol 1982; 8: 1045–1049PubMed
10.
11.
12.
go back to reference Stegman SL, Tromovitch TA, Glogan RG. Treatment of keloids. In: Stegman SJ, editor. Cosmetic dermatologic surgery. 2nd ed. Chicago: Year Book Medical, 1990: 201–206 Stegman SL, Tromovitch TA, Glogan RG. Treatment of keloids. In: Stegman SJ, editor. Cosmetic dermatologic surgery. 2nd ed. Chicago: Year Book Medical, 1990: 201–206
13.
go back to reference Stocker FJ, Shaw Gy. An approach to management of keloids. Arch Otolaryngol Head Neck Surg 1992; 118: 63–67CrossRef Stocker FJ, Shaw Gy. An approach to management of keloids. Arch Otolaryngol Head Neck Surg 1992; 118: 63–67CrossRef
14.
go back to reference Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids. Plast Reconstr Surg 1974; 53: 140–153PubMedCrossRef Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids. Plast Reconstr Surg 1974; 53: 140–153PubMedCrossRef
15.
go back to reference Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46: S63–S97PubMedCrossRef Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46: S63–S97PubMedCrossRef
16.
go back to reference Matas R. The surgical peculiarities of the Negro. Tr Am Surg A 1896; 14: 483–485 Matas R. The surgical peculiarities of the Negro. Tr Am Surg A 1896; 14: 483–485
17.
go back to reference Abrams BJ, Benedetto AV, Humeniuk HM. Exuberant keloidal formation. J Am Osteopath Assoc 1993; 93: 863–865PubMed Abrams BJ, Benedetto AV, Humeniuk HM. Exuberant keloidal formation. J Am Osteopath Assoc 1993; 93: 863–865PubMed
18.
go back to reference Rockwell WE, Cohen IK, Ehrilich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989; 84: 827–837PubMedCrossRef Rockwell WE, Cohen IK, Ehrilich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989; 84: 827–837PubMedCrossRef
19.
go back to reference Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969; 44: 564–566PubMedCrossRef Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969; 44: 564–566PubMedCrossRef
20.
go back to reference Mathangi-Ramakrishnan K, Pothan-Thomas K, Cheyyur R. Study of 1000 patients with keloidal scars in south India. Plast Reconstr Surg 1974; 53: 276–280CrossRef Mathangi-Ramakrishnan K, Pothan-Thomas K, Cheyyur R. Study of 1000 patients with keloidal scars in south India. Plast Reconstr Surg 1974; 53: 276–280CrossRef
21.
go back to reference Davies DM. Scars, hypertrophic scars and keloids. Plast Reconstr Surg 1985; 290: 1056–1058 Davies DM. Scars, hypertrophic scars and keloids. Plast Reconstr Surg 1985; 290: 1056–1058
22.
go back to reference Marneros AG, Norris IE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol 2001; 137: 1429–1434PubMed Marneros AG, Norris IE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol 2001; 137: 1429–1434PubMed
24.
go back to reference Fong EP, Chye LT, Tan WL. Keloids: time to dispel the myths? Plast Reconstr Surg 1999; 104: 1199–1201PubMed Fong EP, Chye LT, Tan WL. Keloids: time to dispel the myths? Plast Reconstr Surg 1999; 104: 1199–1201PubMed
25.
go back to reference Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertophic scars and keloidal scars. Otolaryngol Clin North Am 1995; 28: 1057–1068PubMed Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertophic scars and keloidal scars. Otolaryngol Clin North Am 1995; 28: 1057–1068PubMed
26.
27.
go back to reference Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differeoces between keloid and hypertrophic scars. Am J Pathol 1994; 145: 105–113PubMed Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differeoces between keloid and hypertrophic scars. Am J Pathol 1994; 145: 105–113PubMed
29.
go back to reference Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985; 84: 384–390PubMedCrossRef Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985; 84: 384–390PubMedCrossRef
30.
go back to reference Russell SR, Trupin JS, Kennedy RZ, et al. Glococorticoid regulation of elastin synthesis in human fibroblasts: down regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol 1995; 105: 241–245CrossRef Russell SR, Trupin JS, Kennedy RZ, et al. Glococorticoid regulation of elastin synthesis in human fibroblasts: down regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol 1995; 105: 241–245CrossRef
31.
go back to reference Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989; 9: 1642–1650PubMed Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989; 9: 1642–1650PubMed
32.
go back to reference Kischer CW, Hendrix MJ. Fibronectin in hypertrophic scars and keloids. Cell Tissue Res 1983; 231: 29–37PubMed Kischer CW, Hendrix MJ. Fibronectin in hypertrophic scars and keloids. Cell Tissue Res 1983; 231: 29–37PubMed
33.
go back to reference McCoy BJ, Cohen IK. Effects of various sera on growth kinetics and collagen synthesis by keloid and normal dermal fibroblasts. Plast Reconstr Surg 1981; 67: 505–510PubMedCrossRef McCoy BJ, Cohen IK. Effects of various sera on growth kinetics and collagen synthesis by keloid and normal dermal fibroblasts. Plast Reconstr Surg 1981; 67: 505–510PubMedCrossRef
34.
go back to reference Bettinger DA, Yager DR, Diegelmann RF, et al. The effects of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996; 98: 827–833PubMedCrossRef Bettinger DA, Yager DR, Diegelmann RF, et al. The effects of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996; 98: 827–833PubMedCrossRef
35.
go back to reference Calderon M, Lawreoce WT, Banes AJ. Increased proliferation of keloid fibroblasts in vitro. J Surg Res 1996; 61: 343–347PubMedCrossRef Calderon M, Lawreoce WT, Banes AJ. Increased proliferation of keloid fibroblasts in vitro. J Surg Res 1996; 61: 343–347PubMedCrossRef
36.
go back to reference Younai S, Nichter is, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994; 33: 148–151PubMedCrossRef Younai S, Nichter is, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994; 33: 148–151PubMedCrossRef
37.
go back to reference Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87–96PubMedCrossRef Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87–96PubMedCrossRef
38.
go back to reference Akasaka Y, Fujita K, Ishikawa Y, et al. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 2001; 9: 501–506PubMedCrossRef Akasaka Y, Fujita K, Ishikawa Y, et al. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 2001; 9: 501–506PubMedCrossRef
39.
go back to reference Peltonen J, Hsiao LL, Jaakola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor beta 1 mRNA. J Invest Dermatol 1992; 99: 650–655CrossRef Peltonen J, Hsiao LL, Jaakola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor beta 1 mRNA. J Invest Dermatol 1992; 99: 650–655CrossRef
40.
go back to reference Smith P, Mosiello G, Deloca L, et al. TGF-beta2 activates proliferative scar fibroblasts. J Surg Res 1999; 82: 319–323PubMedCrossRef Smith P, Mosiello G, Deloca L, et al. TGF-beta2 activates proliferative scar fibroblasts. J Surg Res 1999; 82: 319–323PubMedCrossRef
41.
go back to reference Wang X, Smith P, Po LLQ, et al. Exogenous transforming growth factor beta2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 1999; 87: 194–200PubMedCrossRef Wang X, Smith P, Po LLQ, et al. Exogenous transforming growth factor beta2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 1999; 87: 194–200PubMedCrossRef
42.
go back to reference Ghahary A, Shen YJ, Nedelec B, et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995; 148: 25–32PubMedCrossRef Ghahary A, Shen YJ, Nedelec B, et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995; 148: 25–32PubMedCrossRef
43.
go back to reference Yoshimoto H, Hiroshi I, Ohtsuru A, et al. Overexpression of insulin-like growth factor-1 (IGF-1) reeeptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999; 154: 883–889PubMedCrossRef Yoshimoto H, Hiroshi I, Ohtsuru A, et al. Overexpression of insulin-like growth factor-1 (IGF-1) reeeptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999; 154: 883–889PubMedCrossRef
44.
go back to reference Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000; 89: 74–77PubMedCrossRef Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000; 89: 74–77PubMedCrossRef
45.
go back to reference Oriente A, Fedarko NS, Pacocha SE, et al. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000; 292: 988–994PubMed Oriente A, Fedarko NS, Pacocha SE, et al. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000; 292: 988–994PubMed
46.
go back to reference Castagnoli C, Trombotto C, Ariotti S, et al. Expression and role of IL-15 in postburn hypertrophic scars. J Invest Dermatol 1999; 113: 238–245PubMedCrossRef Castagnoli C, Trombotto C, Ariotti S, et al. Expression and role of IL-15 in postburn hypertrophic scars. J Invest Dermatol 1999; 113: 238–245PubMedCrossRef
47.
go back to reference Alaish SM, Yager DR. Diegelmann RF, etal. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995; 30: 949–952PubMedCrossRef Alaish SM, Yager DR. Diegelmann RF, etal. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995; 30: 949–952PubMedCrossRef
48.
go back to reference Bertheim U, Hellstrom S. The distribution of hyaluronan in human skin and mature,hypertrophic and keloid scars. Br J Plast Surg 1994; 47: 483–489PubMedCrossRef Bertheim U, Hellstrom S. The distribution of hyaluronan in human skin and mature,hypertrophic and keloid scars. Br J Plast Surg 1994; 47: 483–489PubMedCrossRef
49.
go back to reference Castagnoli C, Stella M, Magliacani G, et al. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol 1990; 82: 350–354PubMedCrossRef Castagnoli C, Stella M, Magliacani G, et al. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol 1990; 82: 350–354PubMedCrossRef
50.
go back to reference Castagnoli C, Perruccio D, Stella M, et al. The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol 1990; 29: 229–232PubMedCrossRef Castagnoli C, Perruccio D, Stella M, et al. The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol 1990; 29: 229–232PubMedCrossRef
51.
go back to reference Cohen IK, McCoy BJ, Mohanakumar T, et al. Immunoglobulin, complement and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979; 63: 689–695PubMedCrossRef Cohen IK, McCoy BJ, Mohanakumar T, et al. Immunoglobulin, complement and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979; 63: 689–695PubMedCrossRef
52.
go back to reference Kischer CW, Shetlar MR, Shetlar CL, et al. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 1983; 71: 821–825PubMedCrossRef Kischer CW, Shetlar MR, Shetlar CL, et al. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 1983; 71: 821–825PubMedCrossRef
53.
go back to reference Bloch EF, Hall MG, Denson MJ, et al. General immune reactivity in keloid patients. Plast Reconstr Surg 1984; 73: 448–451PubMedCrossRef Bloch EF, Hall MG, Denson MJ, et al. General immune reactivity in keloid patients. Plast Reconstr Surg 1984; 73: 448–451PubMedCrossRef
54.
go back to reference Boyce DE, Ciarrpolini J, Ruge F, et al. Inflammatory cell populations in keloid scars. Br J Plast Surg 2001; 54: 511–516PubMedCrossRef Boyce DE, Ciarrpolini J, Ruge F, et al. Inflammatory cell populations in keloid scars. Br J Plast Surg 2001; 54: 511–516PubMedCrossRef
55.
go back to reference Bernabei P, Rigamonti L, Ariotti S, et al. Fuoctional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues. Burns 1999; 25: 43–48PubMedCrossRef Bernabei P, Rigamonti L, Ariotti S, et al. Fuoctional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues. Burns 1999; 25: 43–48PubMedCrossRef
56.
go back to reference Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathal 1982; 13: 819–824CrossRef Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathal 1982; 13: 819–824CrossRef
57.
go back to reference Louw L, Engelbrecht AM, Cloete F, et al. Impairment in the fatty acid composition of keloidal scars. In: Ronn KV, Nigam S, Marnett LJ, editors. Eicosanoids and other bioactive lipids in cancer inflammation and radiation injury 2. Chapter 116. New York: Plenum Press, 1997: 905–910 Louw L, Engelbrecht AM, Cloete F, et al. Impairment in the fatty acid composition of keloidal scars. In: Ronn KV, Nigam S, Marnett LJ, editors. Eicosanoids and other bioactive lipids in cancer inflammation and radiation injury 2. Chapter 116. New York: Plenum Press, 1997: 905–910
58.
go back to reference Cobbold CA, Sherratt JA. Mathematical modeling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring. J Theor Biol 2000; 204: 257–288PubMedCrossRef Cobbold CA, Sherratt JA. Mathematical modeling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring. J Theor Biol 2000; 204: 257–288PubMedCrossRef
59.
go back to reference Yagi K, Dafalla AA, Osman AA. Does an immune reaction to sebum in wounds cause keloid scars?.: beneficial effect of desensitization. Br J Plast Surg 1979; 32: 223–227PubMed Yagi K, Dafalla AA, Osman AA. Does an immune reaction to sebum in wounds cause keloid scars?.: beneficial effect of desensitization. Br J Plast Surg 1979; 32: 223–227PubMed
60.
go back to reference Cosman B, Wolff M. Correlation of keloid recurrence with completeness of local excision: a negative report. Plast Reconstr Surg 1972; 50: 163–166PubMedCrossRef Cosman B, Wolff M. Correlation of keloid recurrence with completeness of local excision: a negative report. Plast Reconstr Surg 1972; 50: 163–166PubMedCrossRef
61.
go back to reference Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164–178PubMedCrossRef Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164–178PubMedCrossRef
62.
go back to reference Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 1989; 17: 77–80PubMedCrossRef Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 1989; 17: 77–80PubMedCrossRef
63.
go back to reference Lee Y, Minn KW, Baek RM, et al. A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 2001; 46: 135–140PubMedCrossRef Lee Y, Minn KW, Baek RM, et al. A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 2001; 46: 135–140PubMedCrossRef
64.
go back to reference Sclafani AP, Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy. Dermatol Surg 1996; 22: 569–574PubMedCrossRef Sclafani AP, Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy. Dermatol Surg 1996; 22: 569–574PubMedCrossRef
65.
go back to reference Ragoowansi R, Cornes PGS, Glees JP, et al. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg 2001; 54: 504–508PubMedCrossRef Ragoowansi R, Cornes PGS, Glees JP, et al. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg 2001; 54: 504–508PubMedCrossRef
66.
go back to reference Doormos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 1990; 18: 833–839CrossRef Doormos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 1990; 18: 833–839CrossRef
67.
go back to reference Ship AG, Weiss PR, Mincer FR, et al. Sternal keloids: successful treatment employing surgery and adjuvant radiation. Ann Plast Surg 1993; 31: 481–487PubMedCrossRef Ship AG, Weiss PR, Mincer FR, et al. Sternal keloids: successful treatment employing surgery and adjuvant radiation. Ann Plast Surg 1993; 31: 481–487PubMedCrossRef
68.
go back to reference Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol 1999; 72: 1222–1224PubMed Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol 1999; 72: 1222–1224PubMed
69.
go back to reference Cronin TD. The use of a molded splint to prevent contracture after split skin grafting on the neck [letter]. Plast Reconstr Surg 1961; 27: 7CrossRef Cronin TD. The use of a molded splint to prevent contracture after split skin grafting on the neck [letter]. Plast Reconstr Surg 1961; 27: 7CrossRef
70.
go back to reference Bauer PS, Larson DL, Stacey TR, et al. Ultrastructural analysis of pressure treated human hypertrophic scars. J Trauma 1976; 16: 958–967CrossRef Bauer PS, Larson DL, Stacey TR, et al. Ultrastructural analysis of pressure treated human hypertrophic scars. J Trauma 1976; 16: 958–967CrossRef
71.
go back to reference Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg 1978; 1: 579–581PubMedCrossRef Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg 1978; 1: 579–581PubMedCrossRef
72.
go back to reference Russell R, Horlock N, Gault D. Zimmer splintage: a simple effective treatment for keloids following ear-piercing. Br J Plast Surg 2001; 54: 509–510PubMedCrossRef Russell R, Horlock N, Gault D. Zimmer splintage: a simple effective treatment for keloids following ear-piercing. Br J Plast Surg 2001; 54: 509–510PubMedCrossRef
73.
go back to reference Reno F, Grazianetti P, Stella M, et al. Release and activation of matrix metalloproteinase-9 during in vitro mechanical compression in hypertrophic scars. Arch Dermatol 2002; 138: 475–478PubMedCrossRef Reno F, Grazianetti P, Stella M, et al. Release and activation of matrix metalloproteinase-9 during in vitro mechanical compression in hypertrophic scars. Arch Dermatol 2002; 138: 475–478PubMedCrossRef
74.
go back to reference Reno F, Grazianetti P, Cannas M. Effects of mechanical compression on hypertrophic scars: prostaglandin E2 release. Burns 2001; 27: 205–214CrossRef Reno F, Grazianetti P, Cannas M. Effects of mechanical compression on hypertrophic scars: prostaglandin E2 release. Burns 2001; 27: 205–214CrossRef
75.
go back to reference Ahn ST, Mustoe TA, Monafo WW. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989; 106: 781–787PubMed Ahn ST, Mustoe TA, Monafo WW. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989; 106: 781–787PubMed
76.
go back to reference Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993; 19: 529–534PubMed Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993; 19: 529–534PubMed
77.
go back to reference Zouboulis CC, Blume U, Buttner P, et al. Outcomes of cryosurgery in keloids and hypertrophic sars. Arch Dermatol 1993; 129: 1146–1151PubMedCrossRef Zouboulis CC, Blume U, Buttner P, et al. Outcomes of cryosurgery in keloids and hypertrophic sars. Arch Dermatol 1993; 129: 1146–1151PubMedCrossRef
78.
go back to reference Layton AM, Yip J, Cunliffe WI. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994; 130: 498–501PubMedCrossRef Layton AM, Yip J, Cunliffe WI. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994; 130: 498–501PubMedCrossRef
79.
go back to reference Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg 2001; 54: 633–635PubMedCrossRef Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg 2001; 54: 633–635PubMedCrossRef
80.
go back to reference Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for burn scars and contractures. Burns 1983; 9: 201–204CrossRef Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for burn scars and contractures. Burns 1983; 9: 201–204CrossRef
81.
go back to reference Mercer DM. Silicone gel in the treatment of keloids scars. Br J Plast Surg 1989; 42: 83–87PubMed Mercer DM. Silicone gel in the treatment of keloids scars. Br J Plast Surg 1989; 42: 83–87PubMed
82.
go back to reference Abn ST, Monafo WW, Mustoe TA. Topical silicone gel for prevention and treatment of hypertrophic scars. Arch Surg 1991; 126: 499–504CrossRef Abn ST, Monafo WW, Mustoe TA. Topical silicone gel for prevention and treatment of hypertrophic scars. Arch Surg 1991; 126: 499–504CrossRef
83.
go back to reference Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg 1996; 22: 126–130PubMedCrossRef Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg 1996; 22: 126–130PubMedCrossRef
84.
go back to reference Fulton Jr JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloids scars. Dermatol Surg 1995; 21: 947–951PubMedCrossRef Fulton Jr JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloids scars. Dermatol Surg 1995; 21: 947–951PubMedCrossRef
85.
go back to reference De Oliveira GV, Nunes TA, Magna LA. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg 2001; 27: 721–726PubMedCrossRef De Oliveira GV, Nunes TA, Magna LA. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg 2001; 27: 721–726PubMedCrossRef
86.
go back to reference Berman B, Flores F. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic of keloids scars. Dermatol Surg 1999; 25: 484–486PubMedCrossRef Berman B, Flores F. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic of keloids scars. Dermatol Surg 1999; 25: 484–486PubMedCrossRef
87.
go back to reference Gold MH, Foster TD, Adair MA, et al. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 2001; 27: 641–644PubMedCrossRef Gold MH, Foster TD, Adair MA, et al. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg 2001; 27: 641–644PubMedCrossRef
88.
go back to reference Beranak IT. Silicone gel sheeting for the management of hypertrophic and keloids scars: the mechanism of its action. Dermatol Surg 1997; 23: 401–405CrossRef Beranak IT. Silicone gel sheeting for the management of hypertrophic and keloids scars: the mechanism of its action. Dermatol Surg 1997; 23: 401–405CrossRef
89.
go back to reference Darzi MA, Chowdri NA, Kaul SK, et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992; 45: 374–379PubMedCrossRef Darzi MA, Chowdri NA, Kaul SK, et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992; 45: 374–379PubMedCrossRef
90.
go back to reference Griffith BH. The treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1966; 38: 202–208PubMedCrossRef Griffith BH. The treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1966; 38: 202–208PubMedCrossRef
91.
go back to reference Griffith BH, Monroe CW, McKinney P. A follow-up study on the treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1970; 46: 145–1450PubMedCrossRef Griffith BH, Monroe CW, McKinney P. A follow-up study on the treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg 1970; 46: 145–1450PubMedCrossRef
92.
go back to reference Chowdri NA, Mattoo MMA, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999; 69: 655–659PubMedCrossRef Chowdri NA, Mattoo MMA, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999; 69: 655–659PubMedCrossRef
93.
go back to reference Kill J. Keloids treated with topical injections of triamcinolone acetonide (Kenalog). Scand J Plast Reconstr Surg 1977; 11: 169–172CrossRef Kill J. Keloids treated with topical injections of triamcinolone acetonide (Kenalog). Scand J Plast Reconstr Surg 1977; 11: 169–172CrossRef
94.
go back to reference Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560–571PubMedCrossRef Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560–571PubMedCrossRef
95.
go back to reference Berman B, FloresF. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755–757PubMedCrossRef Berman B, FloresF. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755–757PubMedCrossRef
96.
go back to reference Conejo-Mir JS, Corbi R. Carbon dioxide laser ablation associated with interferon alfa-2b injection reduces the recurrence of keloids. J Am Acad Dermatol 1998; 39: 1039–1040PubMedCrossRef Conejo-Mir JS, Corbi R. Carbon dioxide laser ablation associated with interferon alfa-2b injection reduces the recurrence of keloids. J Am Acad Dermatol 1998; 39: 1039–1040PubMedCrossRef
97.
go back to reference Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recorminant interferon-gamma in the treatment of keloidal scarring: Clinical and histologic findings. Arch Dermatol 1990; 126: 1295–1302PubMedCrossRef Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recorminant interferon-gamma in the treatment of keloidal scarring: Clinical and histologic findings. Arch Dermatol 1990; 126: 1295–1302PubMedCrossRef
98.
go back to reference Wong TW, Chiu HC, Yip KM. Intralesional interferon alfa-2b has no effect in the treatment of keloids. Br J Dermatol 1994; 130: 683–685PubMedCrossRef Wong TW, Chiu HC, Yip KM. Intralesional interferon alfa-2b has no effect in the treatment of keloids. Br J Dermatol 1994; 130: 683–685PubMedCrossRef
99.
go back to reference Al-Khawajah MM. Failure of interferon alpha-2b in the treatment of mature keloids. Int J Dermatol 1996; 35: 515–517PubMedCrossRef Al-Khawajah MM. Failure of interferon alpha-2b in the treatment of mature keloids. Int J Dermatol 1996; 35: 515–517PubMedCrossRef
100.
go back to reference Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999; 25: 224–232PubMedCrossRef Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999; 25: 224–232PubMedCrossRef
101.
go back to reference Uppal RS, Khan U, Kakar S, et al. The effects of a single dose of 5-fluorouracil on keloids scars: a clinical trial of tirred wound irrigation after extralesional excision. Plast Reconstr Surg 2001; 108: 1218–1224PubMedCrossRef Uppal RS, Khan U, Kakar S, et al. The effects of a single dose of 5-fluorouracil on keloids scars: a clinical trial of tirred wound irrigation after extralesional excision. Plast Reconstr Surg 2001; 108: 1218–1224PubMedCrossRef
102.
go back to reference Abergel RP, Dwyer RM, Meeker CA, et al. Laser treatment of keloids: a clinical trial and an in vitro study with Nd: YAG laser. Lasers Surg Med 1984; 4: 291–295PubMedCrossRef Abergel RP, Dwyer RM, Meeker CA, et al. Laser treatment of keloids: a clinical trial and an in vitro study with Nd: YAG laser. Lasers Surg Med 1984; 4: 291–295PubMedCrossRef
103.
go back to reference Apfelberg DB, Maser MR, White DN, et al. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989; 9: 382–388PubMedCrossRef Apfelberg DB, Maser MR, White DN, et al. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989; 9: 382–388PubMedCrossRef
104.
go back to reference Apfelberg DB, Maser MR, Lash H, et al. Preliminary results of argon and carbon dioxide laser treatment of keloids scars. Lasers Surg Med 1984; 4: 283–290PubMedCrossRef Apfelberg DB, Maser MR, Lash H, et al. Preliminary results of argon and carbon dioxide laser treatment of keloids scars. Lasers Surg Med 1984; 4: 283–290PubMedCrossRef
105.
go back to reference Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophic and keloids scars. Lasers Surg Med 1984; 3: 271–277PubMedCrossRef Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophic and keloids scars. Lasers Surg Med 1984; 3: 271–277PubMedCrossRef
106.
go back to reference Hulsbergen-Henning JP, Roskam Y, van Gemert MJ. Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med 1986; 6: 72–77PubMedCrossRef Hulsbergen-Henning JP, Roskam Y, van Gemert MJ. Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med 1986; 6: 72–77PubMedCrossRef
107.
go back to reference Sherman R, Rosenfeld H. Experieoce with the Nd: YAG laser in the treatment of keloids scars. Ann Plast Surg 1988; 21: 231–235PubMedCrossRef Sherman R, Rosenfeld H. Experieoce with the Nd: YAG laser in the treatment of keloids scars. Ann Plast Surg 1988; 21: 231–235PubMedCrossRef
108.
go back to reference Stern JC, Locente FE. Carbon dioxide laser excision of earlobe keloids: a prospective study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg 1989; 115: 1107–1111PubMedCrossRef Stern JC, Locente FE. Carbon dioxide laser excision of earlobe keloids: a prospective study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg 1989; 115: 1107–1111PubMedCrossRef
109.
go back to reference Alster TS. Improvement of erythematous and hypertrophic scars by the 585nm pulsed dye laser. Ann Plast Surg 1994; 32: 186–190PubMedCrossRef Alster TS. Improvement of erythematous and hypertrophic scars by the 585nm pulsed dye laser. Ann Plast Surg 1994; 32: 186–190PubMedCrossRef
110.
go back to reference Alster TS, Kurban AK, Grove GL, et al. Alteration of argon laser-indoced scars by the pulsed dye laser. Lasers Surg Med 1993; 13: 368–373PubMedCrossRef Alster TS, Kurban AK, Grove GL, et al. Alteration of argon laser-indoced scars by the pulsed dye laser. Lasers Surg Med 1993; 13: 368–373PubMedCrossRef
111.
go back to reference Alster TS, Lewis AB, Rosenbach A. Laser scar revision: comparison of C02 laser vaporization with and without simultaneous pulsed dye laser. Dermatol Surg 1998; 24: 1299–1302PubMedCrossRef Alster TS, Lewis AB, Rosenbach A. Laser scar revision: comparison of C02 laser vaporization with and without simultaneous pulsed dye laser. Dermatol Surg 1998; 24: 1299–1302PubMedCrossRef
112.
go back to reference Alster TS, McMeekin TO. Improvement of facial acne scars by the 585nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 1996; 35: 79–81PubMedCrossRef Alster TS, McMeekin TO. Improvement of facial acne scars by the 585nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 1996; 35: 79–81PubMedCrossRef
113.
go back to reference Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 1998; 102: 2190–2195PubMedCrossRef Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 1998; 102: 2190–2195PubMedCrossRef
114.
go back to reference Alster TS, Williams CM. Treatment of keloids sternotomy scars with the 585nm flashlamp-pumped pulsed dye laser. Laocet 1995; 345: 1198–1200 Alster TS, Williams CM. Treatment of keloids sternotomy scars with the 585nm flashlamp-pumped pulsed dye laser. Laocet 1995; 345: 1198–1200
115.
go back to reference Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol 2001; 45: 557–565PubMedCrossRef Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol 2001; 45: 557–565PubMedCrossRef
116.
go back to reference Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconstr Surg 1995; 95: 84–90PubMedCrossRef Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconstr Surg 1995; 95: 84–90PubMedCrossRef
118.
go back to reference Alster TS. Laser scar revision: comparison of pulsed dye laser with and without intralesional corticosteroids. Dermatol Surg 2002; 29: 25–29CrossRef Alster TS. Laser scar revision: comparison of pulsed dye laser with and without intralesional corticosteroids. Dermatol Surg 2002; 29: 25–29CrossRef
119.
go back to reference Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002; 138: 1149–1155PubMedCrossRef Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002; 138: 1149–1155PubMedCrossRef
120.
go back to reference Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001; 27: 23–27PubMedCrossRef Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001; 27: 23–27PubMedCrossRef
121.
go back to reference Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor beta1 prodoction by keloids and fetal fibroblasts. Arch Facial Plast Surg 2001; 3: 111–114PubMedCrossRef Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor beta1 prodoction by keloids and fetal fibroblasts. Arch Facial Plast Surg 2001; 3: 111–114PubMedCrossRef
122.
go back to reference Chau D, Mancoll JS, Lee S, et al. Tamoxifen down regulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998; 40: 490–493PubMedCrossRef Chau D, Mancoll JS, Lee S, et al. Tamoxifen down regulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998; 40: 490–493PubMedCrossRef
123.
go back to reference Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol 1988; 14: 1275–1276PubMed Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol 1988; 14: 1275–1276PubMed
124.
go back to reference Kim A, DeCarlo J, Cohen C, et al. Are keloids really “gli-loids”?: high-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol 2001; 45: 707–711PubMedCrossRef Kim A, DeCarlo J, Cohen C, et al. Are keloids really “gli-loids”?: high-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol 2001; 45: 707–711PubMedCrossRef
125.
go back to reference Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002; 47: S209–S11PubMedCrossRef Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002; 47: S209–S11PubMedCrossRef
Metadata
Title
Hypertrophic Scars and Keloids
Etiology and Management
Authors
Dr Tina S. Alster
Elizabeth L. Tanzi
Publication date
01-04-2003
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 4/2003
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304040-00003

Other articles of this Issue 4/2003

American Journal of Clinical Dermatology 4/2003 Go to the issue

Adis Drug Profile

Alefacept

Adis Drug Profile

Alefacept

Adis Drug Profile

Alefacept